NCT04533659Completed
Personalized Behavioral Nutrition Intervention in Older AAs With T2D
Personalized Behavioral Nutrition Intervention in Older Asian Americans With Type 2 Diabetes
Source: ClinicalTrials.gov · Last updated 27 Aug 2025
Brief summary (registry, in English)
The rapid growth rate and unique challenges as a new immigrant group call for a better understanding of the social and health needs of the older Asian Americans (AAs) population. Overwhelming numbers of AAs, a fast-growing first-generation immigrant group, suffer from type 2 diabetes (T2D) and its consequences of poorly controlled blood glucose. For the older AAs, there are higher prevalence rates, worse diabetes control, and higher rates of complications due to limited English proficiency and health literacy. Despite the evidence concerning the effects of dietary interventions on glycemic control by well-controlled feeding studies in mainstream Americans, a lack of clinical trials of culturally tailored interventions often imposes serious barriers to translate and implement such fruitful and innovative approaches in individuals from ethnic minority communities such as AAs. The proposed study will use a randomized, controlled design with a sample of 60 AAs aged 65 years or older. Metabolomics methodologies will be incorporated into this research to provide a global picture of metabolites' responses to personalized behavioral nutrition (PBN) intervention. The study results will obtain the necessary information to conduct a meaningful community-based clinical trial to test the effectiveness of PBN in improving dietary patterns and glycemic control in older AAs.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 12 (actual)
- First submitted
- 24 Aug 2020
- Start date
- 1 Aug 2020
- Primary completion date
- 25 Jul 2025
- Lead sponsor
- The University of Texas Health Science Center at San Antonio
- Diseases
- Type 2 diabetes
- NCT number
- NCT04533659
What you commit to
- Study type: Interventional
- Participants enrolled: 12
- From 1 Aug 2020 to the primary completion date, 25 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Physical or mental health conditions that could limit active participation in the study (e.g., severe illness, blindness in both eyes, severe immobility, psychiatric diseases)
- Hematological condition that would affect A1C assay, e.g., hemolytic anemia, sickle cell anemia
Other
- Unable to give informed consent
- People under another diet regime that is different from the ADA recommended diet
Who the study is looking for
- Self-identified as Asian Americans (Chinese, Korean, or South Asian)
- Age 65 years or older
- Residing in the Bexar County area
- Diagnosed with type 2 diabetes; A1C ≥7.5% within 6 months of screening
- Expressing a willingness to participate in all aspects of the study over its full course
- Possession of a smartphone
Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The University of Texas Health Science Center at San Antonio Coordinator of this site? Confirm its status | San Antonio | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.